Eckert & Ziegler SE (XTER:EUZ) Total Equity : €250.3 Mil (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Total Equity?

Eckert & Ziegler SE's total equity for the quarter that ended in Sep. 2024 was €250.3 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Eckert & Ziegler SE Total Equity Historical Data

The historical data trend for Eckert & Ziegler SE's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Total Equity Chart

Eckert & Ziegler SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

138.34

146.36

192.53

213.63

224.09

Eckert & Ziegler SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Equity	Get a 7-Day Free Trial															224.93	224.09	237.01	249.06	250.27

Eckert & Ziegler SE Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Eckert & Ziegler SE's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	439.364	-	215.271
	=	224.1

Eckert & Ziegler SE's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2024 )	-	Total Liabilities(Q: Sep. 2024 )
	=	480.919	-	230.652
	=	250.3

Eckert & Ziegler SE Total Equity Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

1EUZ:Italy EUZd:UK 0NZY:UK

Address

Robert-Rossle-Street 10, Berlin, BB, DEU, 13125

Website

https://www.ezag.com

Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Executives

Dr. Andreas Eckert	Supervisory Board
Frank Perschmann	Supervisory Board
Dr. Hakim Bouterfa	Board of Directors
Prof. Dr. Wolfgang Maennig	Supervisory Board
Dr. Harald Hasselmann	Board of Directors

Eckert & Ziegler SE Headlines

No Headlines